JP2023546764A5 - - Google Patents
Info
- Publication number
- JP2023546764A5 JP2023546764A5 JP2023502585A JP2023502585A JP2023546764A5 JP 2023546764 A5 JP2023546764 A5 JP 2023546764A5 JP 2023502585 A JP2023502585 A JP 2023502585A JP 2023502585 A JP2023502585 A JP 2023502585A JP 2023546764 A5 JP2023546764 A5 JP 2023546764A5
- Authority
- JP
- Japan
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CNPCT/CN2020/102457 | 2020-07-16 | ||
| CN2020102457 | 2020-07-16 | ||
| PCT/CN2021/106892 WO2022012683A1 (en) | 2020-07-16 | 2021-07-16 | Cd19 binding molecules and uses thereof |
Publications (4)
| Publication Number | Publication Date |
|---|---|
| JP2023546764A JP2023546764A (ja) | 2023-11-08 |
| JPWO2022012683A5 JPWO2022012683A5 (https=) | 2024-07-11 |
| JP2023546764A5 true JP2023546764A5 (https=) | 2024-07-11 |
| JP7829546B2 JP7829546B2 (ja) | 2026-03-13 |
Family
ID=79554496
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023502585A Active JP7829546B2 (ja) | 2020-07-16 | 2021-07-16 | Ｃｄ１９結合分子及びその使用 |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US20230192883A1 (https=) |
| EP (1) | EP4182351A4 (https=) |
| JP (1) | JP7829546B2 (https=) |
| KR (1) | KR20230038706A (https=) |
| CN (1) | CN116457464A (https=) |
| AU (1) | AU2021309145A1 (https=) |
| CA (1) | CA3186065A1 (https=) |
| IL (1) | IL299867A (https=) |
| WO (1) | WO2022012683A1 (https=) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US12590148B2 (en) | 2018-11-26 | 2026-03-31 | Nkarta, Inc. | Methods for the simultaneous expansion of multiple immune cell types, related compositions and uses of same in cancer immunotherapy |
| AU2020232691B2 (en) | 2019-03-05 | 2023-06-29 | Nkarta, Inc. | CD19-directed chimeric antigen receptors and uses thereof in immunotherapy |
| JP7846667B2 (ja) | 2020-07-16 | 2026-04-15 | レジェンド バイオテック アイルランド リミテッド | Ｃｄ２０結合分子及びその使用 |
| WO2025029930A1 (en) | 2023-07-31 | 2025-02-06 | Legend Biotech Ireland Limited | Cells overexpressing cd31 and methods of use thereof |
| WO2025137089A1 (en) * | 2023-12-19 | 2025-06-26 | Beam Therapeutics Inc. | Cd19-binding polypeptides, compositions comprising the same, and methods for use thereof |
| WO2025214438A1 (zh) * | 2024-04-10 | 2025-10-16 | 浙江纳米抗体技术中心有限公司 | 结合cd19和/或cd22的抗原结合分子及其用途 |
| WO2026035951A2 (en) | 2024-08-07 | 2026-02-12 | Legend Biotech Ireland Limited | Cells overexpressing cd43 and methods of use thereof |
| WO2026055226A1 (en) | 2024-09-03 | 2026-03-12 | Legend Biotech Ireland Limited | Cells overexpressing b3gnt2 and methods of use thereof |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB0624500D0 (en) * | 2006-12-07 | 2007-01-17 | Istituto Superiore Di Sanito | A novel passive vaccine for candida infections |
| WO2010130832A2 (en) * | 2009-05-15 | 2010-11-18 | Ablynx N.V. | Amino acid sequences directed against dickkopf-1 and polypeptides comprising the same for the treatment of diseases and disorders associated with bone loss and/or osteolytic lesions |
| CA2874083C (en) * | 2014-12-05 | 2024-01-02 | Universite Laval | Tdp-43-binding polypeptides useful for the treatment of neurodegenerative diseases |
| CN105384825B (zh) * | 2015-08-11 | 2018-06-01 | 南京传奇生物科技有限公司 | 一种基于单域抗体的双特异性嵌合抗原受体及其应用 |
| EP3293199B1 (en) * | 2016-09-08 | 2021-01-13 | Heinrich-Heine-Universität Düsseldorf | Chimeric antigen receptors |
| CN108276493B (zh) * | 2016-12-30 | 2023-11-14 | 南京传奇生物科技有限公司 | 一种嵌合抗原受体及其应用 |
| CN106939048A (zh) * | 2017-03-25 | 2017-07-11 | 康众（北京）生物科技有限公司 | 一种CD3ε×CD19双特异性纳米抗体及其制备方法 |
| PL3823990T3 (pl) * | 2018-07-20 | 2026-04-20 | TeneoTwo, Inc. | Przeciwciała łańcucha ciężkiego wiążące się z cd19 |
| JP2022513164A (ja) * | 2018-11-30 | 2022-02-07 | セルラリティ インク． | 胎盤由来同種ｃａｒ－ｔ細胞およびその使用 |
| CN110396128B (zh) * | 2019-03-21 | 2022-09-06 | 南京东极医药科技有限公司 | 抗cd19纳米抗体的制备 |
-
2021
- 2021-07-16 KR KR1020237001629A patent/KR20230038706A/ko active Pending
- 2021-07-16 CN CN202180061115.XA patent/CN116457464A/zh active Pending
- 2021-07-16 AU AU2021309145A patent/AU2021309145A1/en active Pending
- 2021-07-16 US US18/015,508 patent/US20230192883A1/en active Pending
- 2021-07-16 JP JP2023502585A patent/JP7829546B2/ja active Active
- 2021-07-16 CA CA3186065A patent/CA3186065A1/en active Pending
- 2021-07-16 WO PCT/CN2021/106892 patent/WO2022012683A1/en not_active Ceased
- 2021-07-16 IL IL299867A patent/IL299867A/en unknown
- 2021-07-16 EP EP21843054.4A patent/EP4182351A4/en active Pending